| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UK
|
Khakoo, Shelize
|
|
|
18 |
4 |
p. 280-291.e5
|
artikel
|
| 2 |
Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab
|
Pentheroudakis, George
|
|
|
18 |
4 |
p. e370-e384
|
artikel
|
| 3 |
A Phase II Study of Capecitabine/Oxaliplatin With Concurrent Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Anal Canal
|
Eng, Cathy
|
|
|
18 |
4 |
p. 301-306
|
artikel
|
| 4 |
A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer
|
Floudas, Charalampos S.
|
|
|
18 |
4 |
p. e349-e360
|
artikel
|
| 5 |
Clinical Outcomes of Small Bowel Adenocarcinoma
|
Akce, Mehmet
|
|
|
18 |
4 |
p. 257-268
|
artikel
|
| 6 |
Comment on De Felice et al, “Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer in Elderly Patients: Toxicity, Disease Control, and Survival Outcomes”
|
Yavas, Guler
|
|
|
18 |
4 |
p. e368-e369
|
artikel
|
| 7 |
Comparative Oncologic Outcomes of Upper Third Rectal Cancers: A Meta-analysis
|
Clancy, Cillian
|
|
|
18 |
4 |
p. e361-e367
|
artikel
|
| 8 |
Diagnostic Nodes of Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Among Colorectal Cancer Patients: A Swiss National Multicenter Survey
|
Steffen, Thomas
|
|
|
18 |
4 |
p. e335-e342
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
18 |
4 |
p. A1
|
artikel
|
| 10 |
Effect of Body Mass Index on 5-FU-Based Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer; A Pooled Analysis of 5 Randomized Trials
|
Abdel-Rahman, Omar
|
|
|
18 |
4 |
p. e385-e393
|
artikel
|
| 11 |
Efficacy of PD-1 Blockade in Refractory Microsatellite-Stable Colorectal Cancer With High Tumor Mutation Burden
|
Gong, Jun
|
|
|
18 |
4 |
p. 307-309
|
artikel
|
| 12 |
Evaluation of a Fully Automated Idylla Test System for Microsatellite Instability in Colorectal Cancer
|
Li, Xiang
|
|
|
18 |
4 |
p. e316-e323
|
artikel
|
| 13 |
Evolving Treatment Options and Future Directions for Locally Advanced Rectal Cancer
|
Chen, Emerson Y.
|
|
|
18 |
4 |
p. 231-237
|
artikel
|
| 14 |
Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses
|
Lenz, Heinz-Josef
|
|
|
18 |
4 |
p. 269-279.e5
|
artikel
|
| 15 |
KRAS Status as a Predictor of Chemotherapy Activity in Patients With Metastatic Colorectal Cancer
|
Yarom, Nirit
|
|
|
18 |
4 |
p. e309-e315
|
artikel
|
| 16 |
Neoadjuvant Chemotherapy With mFOLFOXIRI Without Routine Use of Radiotherapy for Locally Advanced Rectal Cancer
|
Zhang, Jianwei
|
|
|
18 |
4 |
p. 238-244
|
artikel
|
| 17 |
Neutrophil-related Variables Have Different Prognostic Effect Based on Primary Tumor Location in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy
|
Colloca, Giuseppe Antonio
|
|
|
18 |
4 |
p. e343-e348
|
artikel
|
| 18 |
Next Generation Sequencing Reveals Novel Mutations in Mismatch Repair Genes and Other Cancer Predisposition Genes in Asian Patients with Suspected Lynch Syndrome
|
Ow, Samuel G.W.
|
|
|
18 |
4 |
p. e324-e334
|
artikel
|
| 19 |
Overuse and Limited Benefit of Chemotherapy for Stage II Colon Cancer in Young Patients
|
Birkett, Richard T.
|
|
|
18 |
4 |
p. 292-300
|
artikel
|
| 20 |
Relationship Between Tumor Response and Tumor-Related Symptoms in RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses From 3 Panitumumab Trials
|
Taieb, Julien
|
|
|
18 |
4 |
p. 245-256.e5
|
artikel
|
| 21 |
Safety Report of TAS-102 in a Patient With Reduced DPD Activity
|
Bolzacchini, Elena
|
|
|
18 |
4 |
p. 310-312
|
artikel
|
| 22 |
Table of Contents
|
|
|
|
18 |
4 |
p. A3-A6
|
artikel
|
| 23 |
Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan
|
Fornaro, Lorenzo
|
|
|
18 |
4 |
p. e394-e401
|
artikel
|
Tijdschrift beschrijving